SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-032948
Filing Date
2018-05-14
Accepted
2018-05-14 16:20:06
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-12382_110q.htm 10-Q 540957
2 EX-31.1 a18-12382_1ex31d1.htm EX-31.1 9797
3 EX-31.2 a18-12382_1ex31d2.htm EX-31.2 9801
4 EX-32.1 a18-12382_1ex32d1.htm EX-32.1 5969
5 EX-32.2 a18-12382_1ex32d2.htm EX-32.2 5980
  Complete submission text file 0001104659-18-032948.txt   2923516

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT btai-20180331.xml EX-101.INS 548118
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT btai-20180331.xsd EX-101.SCH 29087
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT btai-20180331_cal.xml EX-101.CAL 26461
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT btai-20180331_lab.xml EX-101.LAB 244829
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT btai-20180331_pre.xml EX-101.PRE 202097
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT btai-20180331_def.xml EX-101.DEF 93952
Mailing Address 780 EAST MAIN STREET BRANFORD CT 06405
Business Address 780 EAST MAIN STREET BRANFORD CT 06405 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38410 | Film No.: 18830903
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences